What's Going on With AbCellera Biologics Stock On Wednesday?
AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'
AbCellera menopause drug cuts hot flashes in mid-stage trial, shares rise
Jazz Pharmaceuticals Gains Oncology Firepower Through AbCellera Collaboration
Jazz Pharma, AbCellera ink antibody deal worth up to $876 million